Related Experiment Video
Updated: Jun 5, 2026

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
Published on: August 15, 2017
Electroconvulsive therapy--efficacy and side-effects.
Kjell Martin Moksnes1, Stein Opjordsmoen Ilner
1Department of Geriatric Psychiatry, Mental Health and Dependence Clinic, Oslo University Hospital, Slottsberget 35, 1385 Asker, Norway. kjellmartin.moksnes@ulleval.no
Electroconvulsive therapy (ECT) showed good immediate effects and rapid recovery in most patients with major depressive disorder. This treatment was found to be safe and well-tolerated for severe mental health conditions.
Area of Science:
- Psychiatry
- Neurology
- Clinical Psychology
Background:
- The efficacy and side effect duration of electroconvulsive therapy (ECT) remain subjects of uncertainty.
- There is a need to understand the indications, effectiveness, response times, and adverse effects associated with ECT.
Purpose of the Study:
- To investigate the indications for ECT.
- To evaluate the efficacy and time to response for ECT.
- To assess the side effects of ECT.
Main Methods:
- Systematic assessment of ECT protocols and medical records from 1960-1995.
- Data collected from three psychiatric wards at Dikemark Mental Hospital, Norway.
Main Results:
- 141 patients underwent 241 ECT series (1960 sessions); major depressive disorder was the primary diagnosis (88%).
- 85% of patients recovered within four weeks of the first ECT; 77% showed improvement within six days.
- 51% of ECT series had noted side effects, with five serious complications; ECT was considered safe and well-tolerated.
Conclusions:
- ECT demonstrates good immediate efficacy with rapid signs of recovery, particularly in the first week.
- Depressed psychotic patients and the elderly appear to respond best to ECT.
- ECT is a relatively safe and well-tolerated treatment for patients with serious and long-lasting psychiatric disorders.
Related Concept Videos
Electroconvulsive Therapy
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...

